UCSF-CAPRA Score for Prostate Cancer Risk

Predicts outcomes of patients post-treatment for prostate cancer.


PSA at diagnosis (ng/mL)

Gleason Score pattern (primary or secondary)

Clinical Stage

Percent biopsy cores positive for cancer


Source: Cooperberg MR, Broering JM, Carroll PR. Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis. JNCI Journal of the National Cancer Institute. 2009;101(12):878-887. doi:10.1093/jnci/djp122.